Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study

NCT07634146 is registered in ClinicalTrials.gov with Miracle Wellness LLC as lead sponsor.

NCT NCT07634146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07634146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Sham Supplement- and Care-as-Usual-Controlled Study to Evaluate Migraceutics® Phase-Specific Dietary Supplement Regimen on Quality of Life, Work Productivity, and Biomarkers in Adult Migraineurs: The Migraceutics® START Study
Lead sponsor
Miracle Wellness LLC
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 8, 2026
Completion date
June 30, 2028
Enrollment
920 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual migraine, menstrual migraine (mm) headaches, migraine, migraine disability, migraine disease, migraine disorder, migraine headache, migraine in adults